New Delhi, March 21 (IANS) Three Indian pharmaceutical companies have launched generic versions of semaglutide injections, after the drug’s patent expired, offering lower‑cost options for patients managing Type 2 diabetes and obesity.The companies, namely Sun Pharma, Zydus Lifesciences, and Dr. Reddy’s Laboratories, launched their variants a day after Hyderabad-based Natco Pharma launched its generic semaglutide injection in India, priced at Rs 1,290 per month.Sun Pharma launched semaglutide…
Trending
- Prathichaya Movie Review (2026): Nivin Pauly Anchors a Riveting Political Thriller on Media, Power & Truth
- Band Melam Movie Review: A Charming Small-Town Romance That Wins You Over
- Best Curd (Dahi) Brands in the USA: What Actually Works for Indian Cooking
- Best Paneer Brand in USA: An Honest Guide for Indian Families Abroad
- Dinacharya: The Ayurvedic Morning Routine – 7 Steps to Start Your Day Right
- Kerala Appam and Vegetable Stew Recipe for Good Friday
- Hot Cross Buns Recipe: Soft, Spiced Easter Buns for Good Friday
- Bela Pana Recipe for Hanuman Jayanti | Odia Bel Ka Sharbat (Sacred Wood Apple Drink)